EU regulator rejects Alzheimer's drug lecanemab on July 26, 2024 Get link Facebook Twitter Pinterest Email Other Apps It said the benefits of the treatment did not outweigh the risk of serious side effects. from BBC News https://ift.tt/eCnTXFK Comments
Comments
Post a Comment